Announcement on Inclusion of Company Products in the National Essential Medicines List (2026 Edition)

Sichuan Kelun Pharmaceutical Co., Ltd.·July 10, 2026·3 pages

✨ AI Summary

Sichuan Kelun Pharmaceutical Co., Ltd. announces that 157 of its main products and those of its subsidiaries have been included in the National Essential Medicines List (2026 Edition), with 35 new additions. This inclusion is expected to facilitate product promotion and market expansion, positively impacting the company's long-term development. However, actual sales performance remains subject to industry policies, market conditions, and clinical demand, carrying inherent uncertainties.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Announcement on Inclusion of Company Products in the National Essential Medicines List (2026 Edition)

The company and its board of directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and that there are no false records, misleading statements, or material omissions.

On July 9, 2026, the National Health Commission, the State Administration of Traditional Chinese Medicine, and the Chinese Center for Disease Control and Prevention jointly issued the "Notice on Printing and Distributing the National Essential Medicines List (2026 Edition)" (Guo Wei Yao Zheng Fa [2026] No. 17). According to statistics, Sichuan Kelun Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") and its holding subsidiaries have 157 main products currently on sale included in the "National Essential Medicines List (2026 Edition)," with 35 new products added this time. The relevant information regarding the newly added products is hereby announced as follows:

I. Product Information

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.